Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants with Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Trial Identifier: 7240-011
Sponsor: MSD
Start Date: November 2024
Primary Completion Date: December 2037
Study Completion Date: December 2037
Condition: Crohn's Disease; Ulcerative Colitis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary – English
Protocol Plain Language Summary – English

Trial Locations

Country Location
Poland, Mazowieckie Warsawa, Mazowieckie, Poland, 03-580
Poland, Zachodniopomorskie Szczecin, Zachodniopomorskie, Poland, 71-685
United States, CT Bristol, CT, United States, 06010
United States, MI Ypsilanti, MI, United States, 48197
United States, MO Liberty, MO, United States, 64068
United States, TX Garland, TX, United States, 75044
United States, TX San Antonio, TX, United States, 78229
United States, TX Southlake, TX, United States, 76092-9167
United States, TX Tyler, TX, United States, 75701
United States, WA Tacoma, WA, United States, 98405